Ramona Murr

Title: Ramona Murr: Innovator in Bispecific Antibodies

Introduction

Ramona Murr is a prominent inventor based in Zurich, Switzerland. She has made significant contributions to the field of biopharmaceuticals, particularly in the development of bispecific antibodies. With a total of 2 patents, her work has the potential to impact cancer treatment and immunotherapy.

Latest Patents

Ramona's latest patents include innovative bispecific antibodies targeting CD3EPSILON and ROR1. The first patent relates to the manufacture and use of these bispecific antibodies, which are designed to engage both ROR1 and CD3, enhancing the immune response against cancer cells. The second patent focuses on bispecific antibodies against CD3 and BCMA, detailing a unique structure where the variable domains in the light and heavy chains are interchanged. This invention also specifies modifications at certain amino acid positions to improve efficacy.

Career Highlights

Throughout her career, Ramona has worked with notable companies such as Engmab AG and Bristol-Myers Squibb Company. Her experience in these organizations has allowed her to refine her expertise in antibody development and therapeutic applications.

Collaborations

Ramona has collaborated with esteemed colleagues, including Minh Diem Vu and Klaus Strein. These partnerships have fostered a collaborative environment that enhances innovation in her research.

Conclusion

Ramona Murr is a trailblazer in the field of bispecific antibodies, with a focus on advancing cancer therapies. Her patents and collaborations reflect her commitment to innovation and improving patient outcomes.